Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis

Publication

Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis

Journal Paper/Review - Nov 28, 2016

Navarini Alexander A, Bignucolo Olivier, Meyer Benedikt, Meienberg Fabian, Mehling Matthias, Jeker Lukas T, Heijnen Ingmar, Daikeler Thomas D, Gebbers Jan-Olaf, Grimbacher Bodo, Sansom David M, Jeker Raphael, Hess Christoph, Jauch Annaise, Kistner Anne, Bigler Marc, Hruz Petr, Berger Christoph T, Hou Tie Zheng, Schwab Charlotte, Gabrysch Annemarie, Higgins Rebecca, Frede Natalie, Padberg Sgier, Kämpe Olle, Burgener Anne-Valérie, Marquardsen Florian, Baldin Fabian, Recher Mike

Citation

Navarini A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker L, Heijnen I, Daikeler T, Gebbers J, Grimbacher B, Sansom D, Jeker R, Hess C, Jauch A, Kistner A, Bigler M, Hruz P, Berger C, Hou T, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg S, Kämpe O, Burgener A, Marquardsen F, Baldin F, Recher M. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. J Allergy Clin Immunol 2016; 139:1043-1046.e5.

Type

Journal Paper/Review (English)

Journal

J Allergy Clin Immunol 2016; 139

Publication Date

Nov 28, 2016

Issn Electronic

1097-6825

Pages

1043-1046.e5